Strides Pharma Science announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Formulations Facility
of Strides Alathur, a wholly owned subsidiary of the Company, at Alathur, Chennai during the week of 01 April 2024 to 05 April 2024. The inspection closed with two observations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
